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the macroscale effects that occur with varying 
concentrations of GNPs.  
 
Material and Methods: Within our model, concentrations of 
NPs were simulated by calculating the inter-particle spacing 
of various concentrations, where this spacing was used to 
model a controllable concentration, whilst minimizing 
computational time. Investigations were carried out on the 
effect of concentration over a range of clinically relevant 
concentrations in line with previous studies (0.01 mg/ml, 0.1 
mg/ml and 6.5 mg/ml) [1], [2], [3] at two incident proton 
energies (60 MeV and 226 MeV). Various results were 
recorded, such as the energy deposited across the phantom, 
types of secondary particles produced, the particle track 
lengths and energy deposited by secondary particles. 
 
Results: The results highlight a measurable shift of the distal 
edge (Fig.1) in the order of millimeters due to the 
introduction of gold, which can be seen predominantly at 
high concentrations (6.5 mg/ml) achievable through direct 
injection. This shift was deemed to be energy dependent, 
where at lower energies (60 MeV) it was on the order of 
microns. As demonstrated by other groups, the enhancement 
was attributed to an increase in the number of secondary 
electrons, which was proportional to GNP concentration as 
expected. Our model demonstrates that the magnitude of the 




Figure 1: A zoomed in section of the peak, where the plot 
shows readings at every millimeter using a 226 MeV proton 
beam, highlighting the differences due to gold 
concentrations. 
 
Conclusion: This study has demonstrated bulk effects of 
multiple NPs on dosimetry, extending previous work on single 
NP models by other groups [4]. Results show that injectable 
concentrations can affect the range of protons, proving to be 
more significant at higher energies. Future work will 
investigate the effects that GNPs can have on treatment 
plans, assessing any changes that need to be made.  
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Purpose or Objective: A methodology has been developed 
for comprehensive clinical quality audits of radiation therapy 
programmes called Quality Assurance Team for Radiation 
Oncology (QUATRO). The purpose of these audits, which are 
distinct from accreditation, is to assist the audited centres in 
identifying and implementing opportunities for improving the 
quality of services offered to patients. Aggregating the 
findings from audits carried out over 10 years in Europe sheds 
light on the degree to which various dimensions of quality are 
satisfied and suggests interventions which are likely to be 
effective in improving quality in the audited centres. 
 
Material and Methods: Thirty one centres in Europe have 
been audited with this methodology since 2005. The 
voluntary, confidential audits are conducted by 
multidisciplinary teams and take 5 days on-site to complete. 
Reports to the audited centres include both commendations, 
i.e. positive findings, and recommendations for quality 
improvement. A subset of the audited centres were 
designated Centres of Competence (CCs) through QUATRO. A 
coding key has been developed to aggregate and analyse the 
extensive data generated from this audit series. 
 
Results: 600 commendations and 759 recommendations for 
improvement were noted in the 31 audit reports. Positive 
attributes of the audited centres included patient 
centredness, communication, facilities (with the marked 
exception of the availability of treatment units) and quality 
control. Areas for improvement included staffing and 
equipment levels, professional development, documentation 
and quality management. Overall, 10 centres were 
designated as CCs. Of the 600 commendations, 220 were 
given to 10 CCs and 380 to other centres. Of the 759 
recommendations, CCs received 82 while the other centres 
677. The levels of physicists and RTT staffing generally met 
international recommendations in CCs whereas in the other 
centres major staff shortages were recorded. RTT 
understaffing was most acute but other staff groups also 
needed strengthening. Education, training and professional 
development of all staff, but especially RTTs, was seen as a 
weakness in many centres. 
 
Conclusion: QUATRO audits provided the radiotherapy 
centres with an opportunity for an in depth analysis of their 
practices. The detailed reports constitute a template for 
practice improvement and highlight the need to develop 
strategies on the future development of radiotherapy 
services. The analysis of the 31 audits has also identified the 
need for common action items for enhancing the quality of 
radiotherapy in the audited centres. In particular, there is a 
need for extending the reach of educational programmes and 
for expanding the educational offerings to include quality 
management and associated topics. 
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Purpose or Objective: NHS England selected 17 centres of 
varying experience to take part in the Commissioning through 
Evaluation (CtE) programme in order to improve access to 
SABR for patients with Oligometastatic disease. A QA group 
was formed from members of a national trials QA group and a 
national SABR development group to ensure patient safety 
and treatment quality across participating centres, which 
utilise a variety of different equipment and techniques. 
 
